HYBRID EVENT: You can participate in person at Baltimore, Maryland, USA or Virtually from your home or work.
Speaker at International Cancer Conference 2022 - Veronica James
Keynote Presentation (In-Person)
Veronica James, Australian National University, Australia

Every cancer sends out a type-specific signal, as soon as it starts, thus providing the earliest possible diagnosis of the cancer by the cancer itself. These signals can be detected as specific alterations in the low angle X-ray diffraction patterns for skin and/or hair. In [....] » Read More

Speaker at International Cancer Conference 2022 - Michael Thompson
Keynote Presentation (In-Person)
Michael Thompson, University of Toronto, Canada

Will be Updated Soon...

Speaker at International Cancer Conference 2022 - Atif A Ahmed
Keynote Presentation (In-Person)
Atif A Ahmed, Seattle Children’s Hospital, United States

Rhabdomyosarcoma exhibits a complex prognostic algorithm based on histologic, biologic and clinical parameters. In contrast to alveolar rhabdomyosarcoma, embryonal (ERMS) and spindle cell and sclerosing rhabdomyosarcoma (SRMS) histologic types exhibit more heterogenous molecular [....] » Read More

Speaker at International Cancer Conference 2022 - Shinya Tajima
Keynote Presentation (In-Person)
Shinya Tajima, NHO. Shizuoka Medical Centre, Japan

Breast papillary lesions exhibit broad range. Tajima et al. reported in discrimination between benign intraductal papilloma (IDP) and malignant endocrine ductal carcinoma in situ (E-DCIS), new marker of CD56 is useful for discriminating between benign and malignant. Hence, detect [....] » Read More

Speaker at International Cancer Conference 2022 - George Zachos
Keynote Presentation (In-Person)
George Zachos, University of Crete, Greece

Increasing evidence indicates that cancer metastasis is regulated by specific genetic pathways independent of those controlling tumorigenesis and cancer growth. WASF3, a Wiskott-Aldrich syndrome protein family member, appears to play a major role not only in the regulation of act [....] » Read More

Speaker at International Cancer Conference 2022 - Haiying Bao
Oral Presentation
Haiying Bao, Jilin Agricultural University, China

The mushroom Inonotus hispidus is traditional Chinese medicine, which has been used to treat tumor illness for a long history in China. I. hispidus mushroom mainly grows on five different tree species (Morus alba L., Ulmus macrocarpa Hance, Fraxinus mandshurica Rupr., Ziziphus ju [....] » Read More

Speaker at International Cancer Conference 2022 - Yana Yurevna Kiseleva
Oral Presentation
Yana Yurevna Kiseleva, Russian Scientific Center of Roentgenoradiology, Russian Federation

The adaptation of CAR-therapy for a treatment of solid malignant tumors is currently considered as a highly promising opportunity for future therapies. One of the approaches in primary human T cell engineering effective commonly used for CAR gene delivery is retroviral gene trans [....] » Read More

Speaker at International Cancer Conference 2022 - Giuseppe Ercolano
Oral Presentation
Giuseppe Ercolano, University of Naples Federico II, Italy

Innate lymphoid cells (ILC) are a family of immune cells that are emerging as potent orchestrators of immune responses. In cancer, ILCs display both pro- and antitumorigenic functions depending on the nature of the tumor and the involved ILC subset. Little is known about the ILC& [....] » Read More

Speaker at International Cancer Conference 2022 - Romi Gupta
Oral Presentation (Virtual)
Romi Gupta, University of Alabama, United States

Ovarian cancer is the leading cause of gynecological malignancy-related deaths. Current therapies for ovarian cancer do not provide meaningful and sustainable clinical benefits, highlighting the need for new therapies. We show that the histone H3K79 methyltransferase disruptor of [....] » Read More

Speaker at International Cancer Conference 2022 - Andrea Martisova
Poster Presentation
Andrea Martisova, Masaryk University, Czech Republic

Epithelial to mesenchymal transition (EMT) is one of the key processes in tumour progression and metastasis development. TGF-β signaling plays an important role in this process, and through a cascade of signaling events, it enhances the transcription of EMT drivers. Recently [....] » Read More

Speaker at International Cancer Conference 2022 - Neema Tiwari
Poster Presentation
Neema Tiwari, Swami Vivekanand Subharti University, India

Polycythaemia vera (PV) belongs to the group of myeloproliferative neoplasms with excessive increase in hemoglobin levels. They are clinically characterized by nonspecific symptoms such as fatigability, pruritus, early satiety due to splenomegaly, increased risk of infections, an [....] » Read More

Speaker at International Cancer Conference 2022 - Rosie Dew
Poster Presentation
Rosie Dew, University of Sunderland, United Kingdom

Background: Colorectal cancer is the fourth most common cancer in the UK.  Socio-economic disparities are apparent in colorectal cancer survival in the UK and elsewhere. However, it is not known whether socio-economic status has a direct influence on survival or whether it o [....] » Read More

Speaker at International Cancer Conference 2022 - Sara Mikhael
Poster Presentation (Virtual)
Sara Mikhael, Saint-Joseph University, Lebanon

Improving response rates in Ovarian cancer is an urgent clinical issue. Drug repurposing offers a safe and a relatively fast alternative to the conventional methods for oncological drug discovery. Both, metformin, a biguanide approved to treat diabetes, and simvastatin, an HMG-Co [....] » Read More

Speaker at International Cancer Conference 2022 - Parul Sharma
Poster Presentation (Virtual)
Parul Sharma, Thapar Institute of Engineering and Technology, India

Lung cancer is one of the most widely reported tumors having high morbidity and mortality rates with an estimated 1.8 million fatalities. Thymidylate synthase (TS) is an important target for chemotherapy treatments and platinum-based therapies since it is the cell's only de n [....] » Read More

Speaker at International Cancer Conference 2022 - Dan Kenner
Poster Presentation (Virtual)
Dan Kenner, ImunoBran Luxembourg and France, France

The aim of study was to assess the effect of Biobran in reducing of chemotherapy induced side effects in terms of tiredness, anorexia, vomiting and hair loss and quality of life in terms of weight loss. Setting: Radiotherapy Department, Nishtar Hospital Multan. Material and Meth [....] » Read More

Speaker at International Cancer Conference 2022 - Luis Filipe de Oliveira Figliolino
Oral Presentation
Luis Filipe de Oliveira Figliolino , University of Mogi das Cruzes, Brazil

Hospital services have increasingly sought the satisfaction of their clients, through which we are able to measure the quality of health care, as well as other measures of behavioral outcomes of patients1. It is believed to have a direct relationship between the degree of satisfa [....] » Read More

Speaker at International Cancer Conference 2022 - Shivi Mudgal nee Goel
Oral Presentation
Shivi Mudgal nee Goel, Sri Ram Murti Smarak Institute of Medical Sciences, India

One of the most frequent types of neoplastic diseases in females worldwide is breast cancer resulting in significant morbidity and mortality. The commonest route of spread of breast tumor cells is via lymphatics and blood. We as anatomists would like to impress upon the lymphatic [....] » Read More

Speaker at International Cancer Conference 2022 - Mahmoud Alrahawy
Oral Presentation
Mahmoud Alrahawy , East Suffolk and North Essex NHS Foundation Trust, United Kingdom

Aim: Locally advanced rectal cancer (LARC) is treated by neoadjuvant chemoradiotherapy (NCRT) followed by surgery after restaging with magnetic resonance imaging (MRI). Texture analysis (TA) is an imaging biomarker that could assess MRIs heterogeneity by measuring grey-level inte [....] » Read More

Speaker at International Cancer Conference 2022 - Dieudonne Molamba Moningo
Oral Presentation
Dieudonne Molamba Moningo, University of Kinshasa, Congo

Objective: Prostate cancer (PCa) is hormone-dependent cancer. In our area, most patients often arrive at the locally advanced stage or the metastatic stage. This justifies the choice of androgen deprivation as the mode of treatment. The objective of this study was to describe the [....] » Read More

Speaker at International Cancer Conference 2022 - Moningo Molamba
Oral Presentation
Moningo Molamba, University Clinics of Kinshasa, Congo

Context and objective: Prostate cancer (CaP) is a hormone-dependent cancer. In our settings, most affected patients often arrive at the locally advanced stage or at the metastatic stage. This justifies the choice of androgen deprivation as a mode of treatment. The objective of [....] » Read More

Speaker at International Cancer Conference 2022 - Dan Kenner
Oral Presentation
Dan Kenner, ImunoBran Luxembourg and France, France

There is an increased interest in alternative treatments that reduce the toxicity of chemotherapy by lowering the drug concentration, whilst maintaining potency against cancer cells. Previous studies have demonstrated that arabinoxylan from rice bran, MGN3/Biobran, sensitizes hum [....] » Read More

Speaker at International Cancer Conference 2022 - Kaifu Chen
Oral Presentation (Virtual)
Kaifu Chen, Harvard Medical School Country, United States

Cancer genes were known to display unique epigenetic features on chromatin of benign cells. Investigations into these features are making it increasingly clear that cancer genes differ from other genes regarding the mechanisms regulating their transcription. It is yet unknown whe [....] » Read More

Speaker at International Cancer Conference 2022 - Yan Leyfman
Oral Presentation (Virtual)
Yan Leyfman, Icahn School of Medicine, United States

Coronavirus disease 2019 (COVID-19), a respiratory illness caused by betacoronavirus SARS-CoV-2, has broad clinical presentations ranging from asymptomatic to fatal outcomes. Studies have demonstrated that patients with severe symptoms, and uncontrolled inflammatory state have po [....] » Read More

Speaker at International Cancer Conference 2022 - Suhas Sampat Kharat
Oral Presentation (Virtual)
Suhas Sampat Kharat, National Cancer Institute, United States

Poly (ADP-ribose) polymerase inhibitor (PARPi) -induced synthetic lethality of BRCA-deficient cells is being utilized to treat breast and ovarian tumors. However, emergence of resistance to PARPi remains a major concern and understanding resistance mechanisms is of utmost clinica [....] » Read More

Speaker at International Cancer Conference 2022 - Anyou Wang
Oral Presentation (Virtual)
Anyou Wang, University of Memphis, United States

All cancers share an endogenous regulatory realm. Understanding this regulatory realm helps to comprehend the universal mechanism of all cancers; however, the conventional approach fails to uncover it due to heterogeneous biological data. This study reveals the endogenous regulat [....] » Read More

Speaker at International Cancer Conference 2022 - Jian Kang
Oral Presentation (Virtual)
Jian Kang, Peter MacCallum Cancer Centre, Australia

The majority of human tumors are characterized by deregulated signaling through the PI3K/RAS/MYC oncogenic network, leading to an increased rate of ribosome synthesis, mRNA translation and hence protein synthesis. Direct targeting of elevated ribosome biogenesis is becoming a new [....] » Read More

Speaker at International Cancer Conference 2022 - Xiaofeng Liu
Oral Presentation (Virtual)
Xiaofeng Liu, Peking University Cancer Hospital & Institute, China

Cancer stem cell (CSC)-related chemoresistance frequently causes poor prognosis of the patients with colorectal cancer (CRC). The discovery of the chemoresistance-relevant molecules and elucidation of the underlying mechanisms will provide potential therapeutic clues for CRC. In [....] » Read More

Speaker at International Cancer Conference 2022 - Yuko Harada
Oral Presentation (Virtual)
Yuko Harada, Kawasaki Municipal Ida Hospital, Japan

As chemotherapy has advanced in recent years, 10-year survival of breast cancer patients has become as high as 79.3% in Japan. However, the prognosis of patients may be hampered by cardiotoxicity of anti-cancer treatment. It is known that Anthracyclines and Trastuzumab cause some [....] » Read More

Speaker at International Cancer Conference 2022 - Melanie Di Benedetto
Oral Presentation (Virtual)
Melanie Di Benedetto, University of Paris, France Metropolitan

Chemoresistance is a complex phenomenon involving intracellular as well as extracellular mechanisms that needs further studies. Among them, cell death inhibition or environmental cells (fibroblast or endothelial cells) interaction are still under studies.  Anti-apoptotic pro [....] » Read More

Speaker at International Cancer Conference 2022 - Mehrasa Nikandish
Oral Presentation (Virtual)
Mehrasa Nikandish, University of Georgia, Georgia

Presentation will be about cancer drugs market which is popular for the treatment

Speaker at International Cancer Conference 2022 - Nadia Senhaji
Oral Presentation (Virtual)
Nadia Senhaji, Moulay Ismail University of Meknes, Morocco

Despite important advances in the management of tumors in recent decades, glioblastoma (GBM) remains one of the deadliest human cancers. In fact, GBM presents the lowest median observed survival of all primary malignant brain and other CNS tumors (8 months). This poor prognosis i [....] » Read More

Speaker at International Cancer Conference 2022 - Soumik Laha
Oral Presentation (Virtual)
Soumik Laha, Bengal College of Pharmaceutical Sciences & Research, India

Tamoxifen, an anticancer drug which acts by competitive binding to estrogen receptor by blocking G1 phase of cell cycle to slow cell proliferation by reduction of transcription of estrogen regulated genes. Tamoxifen which was synthesized in 1962 and first discovered as compoun [....] » Read More

Speaker at International Cancer Conference 2022 - Dipika Bumb
Oral Presentation (Virtual)
Dipika Bumb, M.S. Ramaiah University of Life and Allied Sciences, India

Cancers of the lip, oral cavity, hypopharynx, oropharynx and larynx are known collectively as mouth and oral cancers. Of these, cancers of the lip and oral cavity are the most common, with more than 377,700 cases worldwide in 2020. (GLOBOCAN). In India, the common leading cancer [....] » Read More

Speaker at International Cancer Conference 2022 - Ankit Naik
Oral Presentation (Virtual)
Ankit Naik, Ahmedabad University, India

Epigenetic alterations play an important part in carcinogenesis. Different biological responses, including cell proliferation, migration, apoptosis, invasion, and senescence, are affected by epigenetic alterations in cancer. In addition, growth factors, such as transforming growt [....] » Read More

Speaker at International Cancer Conference 2022 - Punam Kumari Mandal
Oral Presentation (Virtual)
Punam Kumari Mandal, Tribhuvan University, Nepal

One of the most prevalent cancers in the world, oral cancer is also one of the leading causes of mortality in some areas, such as South-Central Asia, and is a significant public health issue. Oral cancer is the third most prevalent cancer in women and the most common cancer [....] » Read More

Speaker at International Cancer Conference 2022 - Samiah Shahid
Oral Presentation (Virtual)
Samiah Shahid, The University of Lahore , Pakistan

MicroRNAs have shown its role in cell proliferation, apoptosis and pathogenesis of acute lymphoblastic leukemia (ALL). Current diagnosis of ALL comprises invasive and inconvenient procedures including bone marrow biopsy. In spite of recent advancements in the treatment of ALL, st [....] » Read More

Speaker at International Cancer Conference 2022 - Timothy Makumbi Kabanda
Oral Presentation (Virtual)
Timothy Makumbi Kabanda, Makerere University, Uganda

The incidence of this early onset breast cancer in Uganda has tripled if compared to levels of 1961.Breast cancer in these women is peculiar in its progression and aggressiveness yet hardly an answer has been offered for those characteristics. The ray of hope has emerged through [....] » Read More

Speaker at International Cancer Conference 2022 - Ibrahim Yaseen
Oral Presentation (Virtual)
Ibrahim Yaseen, University of Al-Hamdaniya, Iraq

Tetraspanin proteins cross the membrane four times and span the cell surface to form two extracellular loops (EC1 and EC2) and one small intracellular loop, and typically short cytoplasmic N- and C-termini. They are involved in many biological pathways such as viral, bacterial, a [....] » Read More

Speaker at International Cancer Conference 2022 - Ali Mamivand
Oral Presentation (Virtual)
Ali Mamivand, Tehran University of Medical Sciences, Iran (Islamic Republic of)

Long non-coding RNAs (lncRNAs) are widely known for their various functions in cancer from tumor initiation to tumor progression and metastasis. Gliomas are the most prevalent primary forms of brain tumor, classified into grades I to IV according to their malignant histological f [....] » Read More

Speaker at International Cancer Conference 2022 - Brandon Lucke Wold
Oral Presentation (Virtual)
Brandon Lucke Wold, University of Florida, United States

Breast cancer metastasis is a continued concern for patients with recent development in our understanding of disease progression. In this paper, we highlight the pathophysiology behind breast cancer metastasis. Blood brain barrier disruption plays a critical component in progress [....] » Read More

Speaker at International Cancer Conference 2022 - Nicola Manfrini
Oral Presentation (Virtual)
Nicola Manfrini, INGM Institute, Italy

FAM46C is an oncosuppressor gene which is found mutated in approximately 10% of multiple myeloma (MM) patients. Recently, we proposed a model to explain FAM46C mode of action in MM. In highly-secreting MM cells, FAM46C regulates intracellular trafficking and protein secretion dyn [....] » Read More

Speaker at International Cancer Conference 2022 - Ogbonna Collins Nwabuko
Oral Presentation (Virtual)
Ogbonna Collins Nwabuko, University of Calabar, Nigeria

The quality and disability adjusted life-years are the two predictive markers of average life expectancy of any patient. In Multiple myeloma (MM), the duos are the functions of the stage of presentation of primary disease and the impact of the therapeutic (anti-myeloma) intervent [....] » Read More

Speaker at International Cancer Conference 2022 - Roque Gabriel Wiseman Pinto
Oral Presentation (Virtual)
Roque Gabriel Wiseman Pinto, Goa Medical College, India

In the pediatric age group, Wilms Tumor (Nephro blastoma), is the commonest (85%). The others being Congenital Mesoblastic Nephroma, Clear Cell Sarcoma and Rhabdoid Tumor. Wilms Tumor is a Malignant Embryonal Tumor arising from the Nephrogenic blastema and has 3 components bla [....] » Read More

Speaker at International Cancer Conference 2022 - Mai Lan Ho
Oral Presentation (Virtual)
Mai Lan Ho, Nationwide Children’s Hospital, United States

We will discuss modern updates in imaging and classification of brain tumors. First, we will provide an overview of key World Health Organization 2021 changes in nomenclature. Next, we will summarize the utility of basic and advanced imaging techniques for brain tumors. The major [....] » Read More

Speaker at International Cancer Conference 2022 - Shwetima Chaudhary
Oral Presentation (Virtual)
Shwetima Chaudhary, AIIMS National Cancer Institute, India

Vulvar cancer is a rare gynecological malignancy with incidence rates steadily increasing over the past 10 years. Despite aggressive treatment, recurrent disease is common. The goal of this case report is to give an overview of the techniques for interstitial brachytherapy [....] » Read More

Speaker at International Cancer Conference 2022 - Li Hua Zhou
Oral Presentation (Virtual)
Li Hua Zhou, Anhui Medical University, China

The aim of this study was to explore the factors that are associated with posttraumatic growth (PTG) among spouses of women diagnosed with gynecological cancer (GC).

Speaker at International Cancer Conference 2022 - Djoko Agung Priyambodo
Poster Presentation
Djoko Agung Priyambodo, Sebelas Maret University, Indonesia

Introduction Inhalation of carbogen (95% oxygen / 5% carbon dioxide) and nicotinamide is said to improve intratumor oxygenation and improve post-therapy outcomes (radiotherapy and chemotherapy). This is evidenced in cancer patients who obtained improvements in gradient recalled e [....] » Read More

Watsapp